Validation of clinical risk models for predicting COVID-19 severity

Emerg Med J. 2022 Aug 23:emermed-2021-211821. doi: 10.1136/emermed-2021-211821. Online ahead of print.

Authors

Rahul Aggarwal¹, Timothy S Anderson^{1

2}, Aditya Mohanty^{1

2}, Adlin Pinheiro², Long Ngo^{1

2}, Andrew Ahn², Neal Peterson², Mark Dunlop², Thomas Mawson², Taliya Lantsman², Natalia Forbath², Jennifer P Stevens^{1

2}, Shoshana J Herzig^{3

2}

Affiliations

¹ Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
² Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA sherzig@bidmc.harvard.edu.

PMID: 35998921
DOI: 10.1136/emermed-2021-211821

No abstract available

Keywords: COVID-19.